---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029243"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:56:02.791581+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TNF Pharmaceuticals shareholders approve 15x increase in authorized common stock to 250M shares

## Summary
- Authorized common shares increased from 16,666,666 to 250,000,000; amendment filed July 25, 2024.
- Shareholders also approved issuance of shares underlying Series F-1 and G Preferred and warrants for Nasdaq Rule 5635 compliance.
- Share Increase Proposal vote: 819,760 for, 73,259 against, 12,851 abstain.
- Ratification of Morison Cogen as independent auditor for FY2024 passed with 1,536,758 votes for.

## SEC filing metadata
- accession: 0001493152-24-029243
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224029243/0001493152-24-029243-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224029243/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029243
- JSON: https://secwatch.observer/filing/0001493152-24-029243.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029243.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.